Odronextamab
Regeneron
['lymsm']
during the q&amp;a: 5% had pjp infection, none fatal, but speaks to t cell exhaustion from this product. #17icml #lymsm
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈